文献速递流行病学与生物统计基础与转化研究

心电图或心脏磁共振识别的未识别心肌梗死预后:系统综述与荟萃分析

Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis.
PubMed 文献 · BMJ · 2020-05-07

结果显示UMI-ECG和UMI-CMR均与不良长期预后相关,且与临床识别心肌梗死的预后相似,提示对高心血管风险患者筛查未识别心肌梗死可能有助于风险分层。

要点

  • UMI-ECG与全因死亡(HR 1.50)、心血管死亡(HR 2.33)及主要不良心脏事件(HR 1.61)风险升高相关。
  • UMI-CMR与全因死亡(HR 3.21)、心血管死亡(HR 10.79)及主要不良心脏事件(HR 3.23)风险升高相关。
  • UMI-ECG和UMI-CMR的长期预后与临床识别心肌梗死相似,筛查可能有助于高心血管风险患者风险分层。

核心结论

  • UMI-ECG或UMI-CMR与不良长期预后相关,且与临床识别心肌梗死的预后相似。
  • 对高心血管疾病风险患者筛查未识别心肌梗死可能有助于风险分层。

研究设计与样本

  • 系统综述与荟萃分析,纳入前瞻性队列研究。
  • 检索数据库包括PubMed、Embase和Google Scholar。

主要发现

  • 与无心肌梗死相比,UMI-ECG与全因死亡风险升高相关(HR 1.50,95%CI 1.30-1.73)。
  • UMI-ECG与心血管死亡(HR 2.33,95%CI 1.66-3.27)及主要不良心脏事件(HR 1.61,95%CI 1.38-1.89)风险升高相关。
  • UMI-CMR与全因死亡(HR 3.21,95%CI 1.43-7.23)、心血管死亡(HR 10.79,95%CI 4.09-28.42)及主要不良心脏事件(HR 3.23,95%CI 2.10-4.95)风险升高相关。
  • UMI-ECG与无心肌梗死相比,全因死亡绝对风险差为7.50(95%CI 4.50-10.95)/1000人年,心血管死亡为11.04(95%CI 5.48-18.84),主要不良心脏事件为27.45(95%CI 17.1-40.05)。
  • UMI-CMR的相应绝对风险差分别为32.49(95%CI 6.32-91.58)、37.2(95%CI 11.7-104.20)和51.96(95%CI 25.63-92.04)/1000人年。

临床怎么用

  • 对高心血管疾病风险患者,可考虑筛查未识别心肌梗死以改善风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the prognosis of unrecognised myocardial infarction determined by electrocardiography (UMI-ECG) or cardiac magnetic resonance imaging (UMI-CMR). DESIGN: Systematic review and meta-analysis of prospective studies. DATA SOURCES: Electronic databases, including PubMed, Embase, and Google Scholar. STUDY SELECTION: Prospective cohort studies were included if they reported adjusted relative risks, odds ratios, or hazard ratios and 95% confidence intervals for all cause mortality or cardiovascular outcomes in participants with unrecognised myocardial infarction compared with those without myocardial infarction. DATA EXTRACTION AND SYNTHESIS: The primary outcomes were composite major adverse cardiac events, all cause mortality, and cardiovascular mortality associated with UMI-ECG and UMI-CMR. The secondary outcomes were the risks of recurrent coronary heart disease or myocardial infarction, stroke, heart failure, and atrial fibrillation. Pooled hazard ratios and 95% confidence intervals were reported. The heterogeneity of outcomes was compared in clinically recognised and unrecognised myocardial infarction. RESULTS: The meta-analysis included 30 studies with 253 425 participants and 1 621 920 person years of follow-up. UMI-ECG was associated with increased risks of all cause mortality (hazard ratio 1.50, 95% confidence interval 1.30 to 1.73), cardiovascular mortality (2.33, 1.66 to 3.27), and major adverse cardiac events (1.61, 1.38 to 1.89) compared with the absence of myocardial infarction. UMI-CMR was also associated with increased risks of all cause mortality (3.21, 1.43 to 7.23), cardiovascular mortality (10.79, 4.09 to 28.42), and major adverse cardiac events (3.23, 2.10 to 4.95). No major heterogeneity was observed for any primary outcomes between recognised myocardial infarction and UMI-ECG or UMI-CMR. The absolute risk differences were 7.50 (95% confidence interval 4.50 to 10.95) per 1000 person years for all cause mortality, 11.04 (5.48 to 18.84) for cardiovascular mortality, and 27.45 (17.1 to 40.05) for major adverse cardiac events in participants with UMI-ECG compared with those without myocardial infarction. The corresponding data for UMI-CMR were 32.49 (6.32 to 91.58), 37.2 (11.7 to 104.20), and 51.96 (25.63 to 92.04), respectively. CONCLUSIONS: UMI-ECG or UMI-CMR is associated with an adverse long term prognosis similar to that of recognised myocardial infarction. Screening for unrecognised myocardial infarction could be useful for risk stratification among patients with a high risk of cardiovascular disease.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Yang Y, Li W, Zhu H, et al. Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2020. PMID: 32381490. doi:10.1136/bmj.m1184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。